Male germ cell death in mouse testes: Possible involvement of Fas and Fas ligand

被引:52
作者
Koji T. [1 ]
机构
[1] Department of Histology, Nagasaki Univ. School of Medicine, Nagasaki 852-8523
来源
Medical Electron Microscopy | 2001年 / 34卷 / 4期
关键词
Apoptosis; Endocrine-disruptors; Fas/FasL system; Ischemia-reperfusion; Male germ cells; Mouse testis; Spermatogenesis;
D O I
10.1007/s007950100018
中图分类号
学科分类号
摘要
Loss of germ cells is very common during various stages of mammalian spermatogenesis. Although cell death, particularly apoptosis, has been implicated, our understanding of the mechanisms underlying germ cell death is still limited. In order to elucidate the extent and mechanism of germ cell death, this review first covers what is known of germ cell degeneration in the normal testes of fetal, neonatal, and adult mice from electron microscopy (EM) and from terminal dUTP nick-end labeling (TUNEL) staining. The issue of whether the Fas and Fas ligand (FasL) system is involved in the induction of germ cell apoptosis in normal and damaged testes is then addressed, including consideration of both the ischemia-reperfusion model of testicular torsion and the estrogen-treated testis model of environmental endocrine disruption. Finally, this review proposes that different molecular pathways may be triggered to induce male germ cell apoptosis, depending upon the physiological and pathological states of the germ cells.
引用
收藏
页码:213 / 222
页数:9
相关论文
共 50 条
  • [31] Enhancement of germ cell apoptosis induced by ethanol in transgenic mice overexpressing Fas Ligand
    Hu, JH
    Jiang, J
    Ma, YH
    Yang, N
    Zhang, MH
    Wu, M
    Fei, J
    Guo, LH
    CELL RESEARCH, 2003, 13 (05) : 361 - 367
  • [32] Expression of Fas/Fas ligand (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC)
    Yoshitaka Fukuzawa
    Kiyoshi Takahashi
    Keiko Furuta
    Tsuneaki Tagaya
    Tetsuya Ishikawa
    Kaori Wada
    Yasukazu Omoto
    Takehiko Koji
    Shinichi Kakumu
    Journal of Gastroenterology, 2001, 36 : 681 - 688
  • [33] Expression of Fas/Fas ligand (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC)
    Fukuzawa, Y
    Takahashi, K
    Furuta, K
    Tagaya, T
    Ishikawa, T
    Wada, K
    Omoto, Y
    Koji, T
    Kakumu, S
    JOURNAL OF GASTROENTEROLOGY, 2001, 36 (10) : 681 - 688
  • [34] A vision of cell death: Fas ligand and immune privilege 10 years later
    Ferguson, Thomas A.
    Griffith, Thomas S.
    IMMUNOLOGICAL REVIEWS, 2006, 213 : 228 - 238
  • [35] Analysis of Fas and Fas Ligand Expression and Function in Lung Cancer Cell Lines
    Li, Yin
    Zheng, Shi-ying
    Jiang, Dong
    Ge, Jin-feng
    2010 3RD INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI 2010), VOLS 1-7, 2010, : 106 - 112
  • [36] Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption
    Choi, HJ
    Ku, JK
    Kim, MY
    Kang, H
    Cho, SH
    Kim, HO
    Park, YM
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (03) : 419 - 425
  • [37] Analysis of Fas and Fas ligand expression and function in lung cancer cell lines
    Kawasaki, M
    Kuwano, K
    Nakanishi, Y
    Hagimoto, N
    Takayama, K
    Pei, XH
    Maeyama, T
    Yoshimi, M
    Hara, N
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (05) : 656 - 663
  • [38] Fas cell surface death receptor/Fas ligand genetic variants in gastric cancer patients: A case-control study
    Asgari, Rezvan
    Bidmeshkipour, Ali
    Mansouri, Kamran
    Bakhtiari, Mitra
    Mozafari, Hadi
    Abdolmaleki, Amir
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 156 (01) : 77 - 82
  • [39] Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants
    Thilenius, ARB
    Braun, K
    Russell, JH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) : 1108 - 1114
  • [40] Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA)
    Wakisaka, S
    Suzuki, N
    Takeba, Y
    Shimoyama, Y
    Nagafuchi, H
    Takeno, M
    Saito, N
    Yokoe, T
    Kaneko, A
    Asai, T
    Sakane, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 114 (01) : 119 - 128